5493-71-0 Usage
Uses
Used in Pharmaceutical Industry:
2-Chloro-1-ethoxy-4-nitrobenzene is used as an intermediate in the synthesis of pharmaceuticals for its ability to be a building block in the creation of various medicinal compounds.
Used in Dye Industry:
2-Chloro-1-ethoxy-4-nitrobenzene is used as an intermediate in the synthesis of dyes due to its potential to contribute to the formation of color-producing compounds.
Used in Organic Chemistry:
2-Chloro-1-ethoxy-4-nitrobenzene is used as a building block in organic chemistry for its role in forming complex organic structures that are essential in various chemical processes.
Used as a Reagent in Chemical Reactions:
2-Chloro-1-ethoxy-4-nitrobenzene is used as a reagent in chemical reactions to facilitate specific transformations or syntheses, taking advantage of its reactive functional groups.
Safety Precautions:
2-Chloro-1-ethoxy-4-nitrobenzene is a potentially hazardous chemical and should be handled and stored with proper safety precautions to ensure the well-being of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 5493-71-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,9 and 3 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 5493-71:
(6*5)+(5*4)+(4*9)+(3*3)+(2*7)+(1*1)=110
110 % 10 = 0
So 5493-71-0 is a valid CAS Registry Number.
5493-71-0Relevant academic research and scientific papers
Indole compound as well as preparation method, pharmaceutical composition and application thereof
-
Paragraph 1331-1336, (2019/12/02)
The invention discloses an indole compound as well as a preparation method, a pharmaceutical composition and an application thereof. Specifically, the invention relates to an indole derivative as shown in a general formula I and a medicinal salt thereof, a preparation method of the indole derivative, a composition containing one or more compounds, and applications of the compounds in preparation of medicines for preventing and/or treating diseases related to IDO1 and/or TDO.
